Human papillomavirus typing with hybrid capture II on archived liquid-based cytologic specimens: is HPV typing always reproducible?

Reproducibility of human papillomavirus (HPV) typing on archived ThinPrep (Cytyc, Boxborough, MA) specimens was evaluated repeating Hybrid Capture II (HCII) (Digene, Gaithersburg, MD) testing after 25 to 40 months (mean, 31.3 months; group 1), 6 to 11 months (mean, 8.4 months; group 2), and 0 to 5 months (mean, 3.5 months; group 3). Another ThinPrep slide was prepared to evaluate cellularity and reproducibility of the cytologic diagnosis. The mean residual relative light units (RLU) calculated for each group showed a strong decrease of RLU values at the second typing (group 1, 21.69%; group 2, 26.47%; and group 3, 32.25% of original values). No residual HPV DNA was shown in group 1 in 8 (13%) of 60 cases or in groups 2 and 3 in 2 (3%) of 60 cases each. These cases were associated mostly with poor cellularity and reproducibility of the initial cytologic diagnosis in the final cytologic examination. Intergroup statistical analysis of mean relative percentages for cases with satisfactory residual cellularity revealed a significant difference only between groups 1 and 3 (P < .05). Although mostly reproducible, HPV typing results by HCII on archived specimens are influenced by material consumption. In addition, results might be affected by some DNA degradation after long-term sample storage.

[1]  Diane Solomon,et al.  Stability of archived liquid‐based cervical cytologic specimens , 2003, Cancer.

[2]  R. Williams,et al.  Comparative Analysis of a Liquid-Based Pap Test and Concurrent HPV DNA Assay of Residual Samples , 2002, Acta Cytologica.

[3]  David R. Scott,et al.  Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible , 2002, Journal of Clinical Microbiology.

[4]  S. Hsueh,et al.  Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. , 2001, American journal of obstetrics and gynecology.

[5]  Y. Soong,et al.  Negative predictive value of human papillomavirus test following conization of the cervix uteri. , 2001, Gynecologic oncology.

[6]  C. Clavel,et al.  Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women , 2001, British Journal of Cancer.

[7]  S. Hsueh,et al.  Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen , 2001 .

[8]  M. Schiffman,et al.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.

[9]  T. Byers,et al.  Prediction of Cervical Intraepithelial Neoplasia Grade 2–3 Using Risk Assessment and Human Papillomavirus Testing in Women With Atypia on Papanicolaou Smears , 2000, Obstetrics and gynecology.

[10]  C. Clavel,et al.  Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. , 1998, Journal of clinical pathology.

[11]  L. Mango,et al.  Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing , 1997, Cancer.